Analysis of TCGA database showed gene amplification of NAMPT and NMNAT2 at relatively high frequency in various types of cancer, including pancreatic, breast, ovarian, and uterine cancers (Fig 4C). This evidence concerns the gene NMNAT2 and uterine cancer.